BackSMS Pharmaceuticals Limited Overview
SMS Pharmaceuticals Limited

SMS Pharmaceuticals Limited Return on Equity

Latest ROE for SMS Pharmaceuticals Limited: 13.88% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

13.88%

Return on Equity

13.88%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

SMS Pharmaceuticals Limited (SMSPHARMA.BO) FAQ

The latest ROE for SMSPHARMA.BO is 13.88%. That is above the sector sector average of 11.3%. Investors often review this figure alongside SMS Pharmaceuticals Limited's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, SMSPHARMA.BO currently prints 13.88% for ROE, while the sector average sits near 11.3%. That is roughly 22.9% above the sector mean. Large gaps often invite a closer look at SMS Pharmaceuticals Limited's growth, margins, and balance sheet.

Return on Equity shows how effectively SMS Pharmaceuticals Limited converts resources into returns. At 13.88%, SMSPHARMA.BO may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SMSPHARMA.BO's ROE (13.88%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.